Muna-GSK alliance to fast-track Alzheimer's disease treatments

Muna-GSK alliance to fast-track Alzheimer's disease treatments

Muna Therapeutics partners with GSK to accelerate Alzheimer's disease treatments through new drug target discovery using MiND-MAP platform. The alliance aims to transform drug discovery for neurodegenerative diseases.

Read More

Did you find this insightful?